Sale!

COL2A1 Gene Legg-Calve-Perthes Disease NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The COL2A1 Gene Legg-Calve-Perthes Disease NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the COL2A1 gene responsible for Legg-Calve-Perthes disease and related bone disorders. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide accurate detection of genetic variations affecting collagen type II production, which is essential for healthy cartilage and bone development. The test is particularly valuable for children experiencing hip pain, limited mobility, or abnormal gait patterns. Results help guide treatment decisions, enable early intervention, and provide crucial information for family planning. Available for only $500 USD, this test offers significant cost savings compared to the regular price of $700 USD.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

COL2A1 Gene Legg-Calve-Perthes Disease NGS Genetic DNA Test

Comprehensive Genetic Testing for Bone and Joint Disorders

The COL2A1 Gene Legg-Calve-Perthes Disease NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for orthopedic conditions affecting children and young adults. This advanced test specifically targets mutations in the COL2A1 gene, which plays a critical role in collagen type II production – the primary structural protein in cartilage and essential for proper bone development and joint health.

What Does This Test Measure and Detect?

Our state-of-the-art NGS Genetic DNA Test comprehensively analyzes the COL2A1 gene to identify:

  • Pathogenic mutations causing Legg-Calve-Perthes disease
  • Genetic variations associated with type II collagenopathies
  • Single nucleotide polymorphisms (SNPs) affecting collagen production
  • Deletions, insertions, and other structural variants in the COL2A1 gene
  • Inheritance patterns for family risk assessment

The test utilizes Next-Generation Sequencing technology, providing unparalleled accuracy in detecting even the most subtle genetic variations that could impact bone development and joint health.

Who Should Consider This Genetic Test?

This comprehensive genetic evaluation is recommended for individuals presenting with:

  • Children experiencing unexplained hip pain or limping
  • Young patients with limited hip mobility or range of motion
  • Individuals with family history of Legg-Calve-Perthes disease
  • Patients with abnormal gait patterns or walking difficulties
  • Children showing signs of avascular necrosis of the femoral head
  • Individuals with suspected collagen type II disorders
  • Patients with multiple joint involvement or early-onset arthritis
  • Families seeking genetic counseling for inheritance risk assessment

Key Benefits of COL2A1 Genetic Testing

Choosing our COL2A1 Gene Legg-Calve-Perthes Disease NGS Genetic DNA Test provides numerous advantages:

  • Early Diagnosis: Enables prompt identification of genetic predisposition to bone disorders
  • Personalized Treatment: Guides orthopedic specialists in developing targeted treatment plans
  • Family Planning: Provides crucial information for genetic counseling and family risk assessment
  • Proactive Management: Allows for early intervention and preventive measures
  • Comprehensive Analysis: Utilizes advanced NGS technology for thorough genetic evaluation
  • Clinical Correlation: Helps connect symptoms with underlying genetic causes

Understanding Your Test Results

Our genetic specialists provide comprehensive interpretation of your COL2A1 test results:

  • Positive Result: Indicates the presence of a pathogenic mutation in the COL2A1 gene, confirming genetic predisposition to Legg-Calve-Perthes disease or related conditions
  • Negative Result: Suggests no detectable mutations in the COL2A1 gene, though clinical correlation with symptoms remains important
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
  • Carrier Status: Determines if an individual carries a single copy of a mutated gene that could be passed to offspring

All results include detailed explanations and recommendations for next steps, with genetic counseling available to help you understand the implications for your health and family.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3-4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified genetic testing facilities ensures accessible, reliable service no matter where you’re located.

Take Control of Your Genetic Health Today

Don’t let uncertainty about genetic bone disorders affect your quality of life. Our COL2A1 Gene Legg-Calve-Perthes Disease NGS Genetic DNA Test provides the clarity and confidence you need for informed healthcare decisions. With our special discounted price of only $500 USD (regularly $700 USD), now is the perfect time to invest in your genetic health.

Ready to schedule your test? Call or WhatsApp us today at +1(267) 388-9828 to book your appointment or speak with our genetic counseling team.

Our dedicated specialists are available to answer your questions, discuss pre-test requirements including clinical history documentation and genetic counseling sessions, and help you take the first step toward understanding your genetic health profile.